info iconCurrently, the share price for Alkem Laboratories Ltd. is delayed.

close icon
Alkem Laboratories Ltd. Logo

Alkem Laboratories Ltd.

₹5,623.85
NSE
--   ( -- %) 1D



  • Prev. Close
    5,623.85
  • Upper Circuit
    6,186.20
  • Lower Circuit
    5,061.50

Analyst Sentiment For Alkem Laboratories Ltd.

Info icon
As recommended by 20 analysts

Returns

Alkem Laboratories Ltd.'s Info & Management

Incorporated in the year 1973, Alkem Laboratories Limited is an Indian pharmaceutical company with a global footprint. It is based in Mumbai, India. The company is actively involved in the research, manufacturing, and sale of pharmaceutical and nutraceutical products.

Business Segment

The company’s operations include:

  • Primary Segment: covers research, manufacturing, and sale of pharmaceutical and nutraceutical products
  • Key Therapeutic Areas: include Anti-infective, Gastrointestinal, Pain Management, and Vitamins/Minerals/Nutrients 
  • Brand Portfolio: are Clavam, Pan, Pan-D, and Taxim-O. Neuro/CNS, A TO Z, XONE SB, ULTIGEST, KEMGLIPTIN, CALKEM, ALKEM DEXA

Geographical Presence

Geographically, the company operates in India, USA, Europe, Latin America and more.

  • President(Sales & Marketing)
    Mr. Mukesh Tiwary
  • Vice President,Chief Information Officer
    Mr. Ramanarayana Parhi
  • Vice President(Corporate Strategy,Business Development)
    Mr. Abhijit Basak
  • Senior Vice President,Head(Sites)
    Mr. Ravinder Chakilam
  • Senior Vice President(API.,R&D Services)
    Mr. Jayprakash Parihar
  • Senior Vice President(Formulations,Manufacturing)
    Mr. Rakesh Tripathi

FAQs on Alkem Laboratories Ltd.

What is the share price of Alkem Laboratories Ltd.?

Alkem Laboratories Ltd. share price is ₹5,493.60 as of November 12, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Alkem Laboratories Ltd.?

The 52-week high and low of Alkem Laboratories Ltd. is ₹6,439.90 and ₹4,289.15 respectively as of November 12, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Alkem Laboratories Ltd.?

The trailing twelve month (TTM) PB ratio of Alkem Laboratories Ltd. is 6.52 as of November 13, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Alkem Laboratories Ltd.?

The Upper Circuit of Alkem Laboratories Ltd. is ₹6,186. The Lower Circuit of Alkem Laboratories Ltd. is ₹5,062.

What is the ROE of Alkem Laboratories Ltd.?

Alkem Laboratories Ltd. reported an ROE of 18.55% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Alkem Laboratories Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Alkem Laboratories Ltd., Promoter held 55.7%, the FII held 9%, DII held 19.2% and the public held 16.1% of the total shares.

How to buy Alkem Laboratories Ltd. Share?

You can easily buy shares of Alkem Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Alkem Laboratories Ltd.?

The fair value of Alkem Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer